has never been used to evaluate drug naive patients with cryptogenic temporal lobe epilepsy, in whom the mechanism of origin and diffusion of the epileptic discharge may differ from that underlying other epilepsies. In a group of patients with cryptogenic temporal lobe epilepsy, never treated with antiepileptic drugs, evidence has been found of significant interictal glucose hypermetabolism in a bilateral neural network including the temporal lobes, thalami, basal ganglia, and cingular cortices. The metabolism in these areas and frontal lateral cortex enables the correct classification of all patients with temporal lobe epilepsy and controls by discriminant function analysis. Other cortical areas-namely, frontal basal and lateral, temporal mesial, and cerebellar cortices-had bilateral increases of glucose metabolism ranging from 10 to 15% of normal controls, although lacking stringent statistical significance. This metabolic pattern could represent a pathophysiological state of hyperactivity predisposing to epileptic discharge generation or diffusion, or else a network of inhibitory circuits activated to prevent the diffusion of the epileptic discharge. with an unknown and occult aetiology.' Although MRI has greatly improved our ability to uncover anatomical lesions in these patients,2 our ignorance of a presumed cause may be due to low sensitivity of our diagnostic tools. The purpose of this study was the assessment of interictal regional cerebral glucose utilisation (rCMRglu) in patients not taking drugs and in whom the clinical diagnosis of cryptogenic epilepsy was made for the first time just before the study. Thus we investigated the early phases of cryptogenic temporal lobe epilepsy and avoided the possibility of artifactual findings due to the effects of antiepileptic treatment.
Subjects and methods

PATIENTS
We studied 13 consecutive patients (10 women and three men, mean age 31-8, range 17-53 years) in whom the diagnosis of cryptogenic temporal lobe epilepsy was made according to standard criteria (table 1).1 None of the patients with temporal lobe epilepsy had ever had a diagnosis of epilepsy before the enrolment in the study, not even those with a long history of disease, probably because of the little impact on their daily life of rare and benign partial seizures. For this reason they had never been treated with antiepileptic drugs.
Their first seizure occurred between six months and 27 years before the diagnosis (mean 4 (SD 7) years) and they reported a variable number of seizures (mean 8 (SD 12) ; range 3-50) during the entire course of the disease.
Eleven patients had only complex partial of view of 55-5 cm and an axial field of view of 5-4 cm. All subjects were studied in the resting state with their eyes open and ears unplugged. Before each study a 20 gauge teflon catheter was inserted into the radial artery, under local anaesthesia; the patients were then positioned in the PET scanner and their heads were restrained by a customised head holder. The orbitomeatal line was symmetrically defined with the aid of low energy laser beams and skin marks and the PET gantry was aligned to obtain axial slices parallel to the orbitomeatal line. Two 10 minute consecutive transmission scans, one for each bed position necessary to examine the whole brain, were performed with a 68Ge/68Ga source external to the subject to measure the coefficients to correct for attenuation of the emitted photons. At the end of the transmission scan each subject received an intravenous injection of Values are means (SD) (95% CI); TLE = temporal lobe epilepsy. tF values adjusted for global hemispheric metabolism (one way ANCOVA). *Significance level set at P < 0-003 according to Bonferroni's correction.
lism in a bilateral neural network including the temporal lobes, thalami, basal ganglia, and cingular cortices. Applying the metabolism of these areas and of lateral frontal regions in the model of discriminant function analysis, all patients with temporal lobe epilepsy and normal controls could be correctly assigned to each category. Although lacking stringent statistical significance, several other cortical areas had bilateral increases of rCMRglu ranging from 10% to 15%. These areas were the frontal basal, frontal lateral, temporal mesial, and cerebellar cortices, all of which are known to be functionally correlated to the significantly hypermetabolic network. By contrast, the rolandic, parietal, and occipital areas showed minimal increases, ranging from 0 5% to 7% in comparison with normal subjects. This finding is surprising because previous interictal studies of patients with refractory temporal lobe epilepsy have shown in most cases unilateral areas of temporal hypometabolism, usually concordant with the side of the EEG abnormalities and with the site of a morphological lesion. ' 20 Our finding of a bilateral hypermetabolic network contrasts with the hypothesis of well localised epileptogenic zones underlying the pathophysiology of cryptogenic temporal lobe epilepsy. This pattern is, however, in agreement with the clinical finding that often in cryptogenic temporal lobe epilepsy neither seizure phenomenology nor EEG are clearly lateralising or localising the epileptogenic zone. For example, in our sample no patient had lateralising signs in their seizures (which were mainly amygdalohippocampal' and secondarily generalised), two patients out of 13 had bilateral EEG abnormalities, and six patients showed lateralising EEGs only during sleep recordings.
The bilateral hypermetabolic network found in a group of untreated patients with cryptogenic temporal lobe epilepsy could represent a pathophysiological state of hyperactivity predisposing to epileptic discharge generation or diffusion, or a network of inhibitory circuits activated to prevent the diffusion of the epileptic discharge originating from a localised epileptogenic zone. In refractory symptomatic temporal lobe epilepsy, focal neuronal loss and gliosis or alterations of synaptic processes seem to be the common causes of interictal glucose hypometabolism,21 whereas the ictal hypermetabolism could be related to energy consuming epileptic activity.3 '7 Postictal hypermetabolism seems to be due to energy expenditure of inhibitory circuits for the restoration of normal membrane polarisation and chemical homeostasis. A similar mechanism could explain our finding of hypermetabolic bilateral networks in patients with cryptogenic temporal lobe epilepsy. Against this hypothesis are the low frequency of their seizures, the mildness of the disease, and the long time (at least 72 hours) between the last seizure and the PET/['8F]FDG study. The hypothesis that the hyperactive network is the underlying pathophysiological basis of the disease seems to be more reasonable and could be confirmed by an ongoing follow up study in the same group of patients during chronic effective treatment with carbamazepine. Indeed, it cannot be ruled out that hypermetabolic networks may actually underlie most epileptic processes and could also be found in patients with refractory temporal lobe epilepsy if it were possible to study them when they were not taking drugs.
Whichever is the neurophysiological interpretation, the finding of a hypermetabolic network in cryptogenic temporal lobe epilepsy suggests the existence of different mechanisms of origin and diffusion of the epileptic discharge and of different functional balance between "normal" and "lesioned" cerebral areas in different types of epilepsies. This in turn points out the need for metabolic studies in other types of epilepsies, such as idiopathic epilepsies or situation related epileptic syndromes.
